Carvédilol EG may be available in the countries listed below.
Ingredient matches for Carvédilol EG
Carvedilol is reported as an ingredient of Carvédilol EG in the following countries:
- France
International Drug Name Search
Carvédilol EG may be available in the countries listed below.
Carvedilol is reported as an ingredient of Carvédilol EG in the following countries:
International Drug Name Search
Relieving symptoms of sinus congestion, pressure, runny nose, and sneezing caused by colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.
Vazotab Chewable Tablets are an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, which relieves congestion and pressure.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Vazotab Chewable Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Vazotab Chewable Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Vazotab Chewable Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Vazotab Chewable Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Vazotab Chewable Tablets.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; dizziness; drowsiness; dry mouth; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blurred vision or other vision changes; confusion; decreased coordination; difficulty urinating or inability to urinate; fainting; fast or irregular heartbeat; hallucinations; mood or mental changes; persistent trouble sleeping; restlessness; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; tremor; wheezing.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Vazotab side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; ringing in the ears; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular breathing; unusually fast, slow, or irregular heartbeat.
Store Vazotab Chewable Tablets at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Vazotab Chewable Tablets out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Vazotab Chewable Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Sawatal LA may be available in the countries listed below.
Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Sawatal LA in the following countries:
International Drug Name Search
Prilinda may be available in the countries listed below.
Ramipril is reported as an ingredient of Prilinda in the following countries:
International Drug Name Search
Generic Name: panitumumab (pan i TUE moo mab)
Brand Names: Vectibix
Panitumumab is a cancer medication. It interferes with the growth of cancer cells and slows their growth and spread in your body.
Panitumumab is used to treat metastatic colorectal cancer that has progressed after treatment with other chemotherapy.
Panitumumab may also be used for other purposes not listed in this medication guide.
Before receiving this medication, tell your doctor if you have any allergies or breathing problems. You may not be able to receive panitumumab, or you may need a dosage adjustment or special tests during treatment.
Some people receiving a panitumumab injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, nauseated, light-headed, itchy, short of breath, or if you have a fever or chills during the injection.
The side effects of panitumumab may not appear when you first start using the medication. Severe skin or eye reactions may occur up to 2 weeks after the start of your treatment. These effects may not clear up for weeks or even months after you stop receiving panitumumab.
This medication may affect a woman's fertility (ability to have children). You may also have irregular menstrual periods while receiving panitumumab.
Before receiving this medication, tell your doctor if you have any allergies or breathing problems. You may not be able to receive panitumumab, or you may need a dose adjustment or special tests to safely receive this medication.
This medication may affect a woman's fertility (ability to have children). You may also have irregular menstrual periods while receiving panitumumab.
Panitumumab is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion, and can take up to 90 minutes to complete.
Before you receive this medication, you may need to undergo a biopsy to make sure panitumumab is the right medication to treat your cancer.
Panitumumab is usually given once every 2 weeks. Follow your doctor's instructions.
Contact your doctor if you miss an appointment for your panitumumab injection.
Seek emergency medical attention if you think you have received too much of this medicine. Symptoms of a panitumumab overdose are unknown.
Some people receiving a panitumumab injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, nauseated, light-headed, itchy, short of breath, or if you have a fever or chills during the injection.
Some of the side effects of panitumumab may not appear when you first start using the medication. Severe skin or eye reactions may occur up to 2 weeks after the start of your treatment. These effects may not clear up for weeks or even months after you stop receiving panitumumab.
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
swelling of your hands or ankles;
acne, dryness, peeling, cracking, bleeding, oozing, pus, or any other sign of skin infection;
cough or wheezing, running out of breath easily;
white patches or sores inside your mouth or on your lips;
drowsiness, restless feeling, confusion, muscle stiffness, fast or uneven heart rate, chest pain;
redness, swelling, or irritation of your eyes or eyelids; or
swelling or infection around your fingernails or toenails.
Less serious side effects may include:
nausea, vomiting, stomach pain;
diarrhea or constipation; or
tired feeling.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with panitumumab. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
See also: Vectibix side effects (in more detail)
Generic Name: sulfacetamide and prednisolone ophthalmic (SUL fa SEET a mide and pred NIS oh lone off THAL mik)
Brand Names: Blephamide, Blephamide S.O.P., Ocu-Lone C
Sulfacetamide is an antibiotic. It is used to treat bacterial infections.
Prednisolone is a steroid. It is used to treat the swelling associated with bacterial infections of the eye.
Sulfacetamide and prednisolone ophthalmic may also be used for purposes other than those listed in this medication guide.
Contact your doctor if your symptoms begin to get worse or if you do not see any improvement in your condition after a few days.
Apply light pressure to the inside corner of your eye (near your nose) after each drop to prevent the fluid from draining down your tear duct.
Do not use sulfacetamide and prednisolone ophthalmic if you have ever had an allergic reaction to a sulfa-based drug.
Use sulfacetamide and prednisolone ophthalmic eyedrops or ointment exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.
To apply the eyedrops:
Shake the drops gently to be sure the medicine is well mixed. Tilt your head back slightly and pull down on your lower eyelid. Position the dropper above your eye. Look up and away from the dropper. Squeeze out a drop and close your eye. Apply gentle pressure to the inside corner of your eye (near your nose) for about 1 minute to prevent the liquid from draining down your tear duct. If you are using more than one drop in the same eye or drops in both eyes, repeat the process with about 5 minutes between drops.
To apply the ointment:
Hold the tube in your hand for a few minutes to warm it up so that the ointment comes out easily. Tilt your head back slightly and pull down gently on your lower eyelid. Apply a thin film of the ointment into your lower eyelid. Close your eye and roll your eyeball around in all directions for 1 to 2 minutes. If you are applying another eye medication, allow at least 10 minutes before your next application.
Apply the missed dose as soon as you remember. However, if it is almost time for your next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.
An overdose of this medication is unlikely to occur. If you do suspect an overdose, wash the eye with water and call an emergency room or poison control center near you. If the drops or ointment have been ingested, drink plenty of fluid and call an emergency center for advice.
Use caution with contact lenses. Wear them only if your doctor approves. After applying this medication, wait at least 15 minutes before inserting contact lenses.
Avoid other eye medications unless your doctor approves.
Serious side effects are not expected with this medication.
Some burning, stinging, irritation, itching, redness, blurred vision, eyelid itching, eyelid swelling, or sensitivity to light may occur.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Do not use this medication with other eyedrops that contain nitrates (e.g., silver nitrate).
Avoid other eye medications unless they are approved by your doctor.
Before using this medication, tell your doctor if you are taking an oral steroid medication such as prednisone (Deltasone, Orasone, others).
Drugs other than those listed here may also interact with sulfacetamide and prednisolone ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.
See also: Vasocidin side effects (in more detail)
GelTears may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
UK matches:
Carbomer is reported as an ingredient of GelTears in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |